ROYAL BANK OF CANADA - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 8 filers reported holding AVENUE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0132
-24.6%
0.00%
Q1 2022$0175
-4.9%
0.00%
Q4 2021$0184
-12.0%
0.00%
Q3 2021$0
-100.0%
209
-83.3%
0.00%
Q2 2021$3,000
-40.0%
1,255
+65.1%
0.00%
Q1 2021$5,000
+25.0%
760
+12.4%
0.00%
Q4 2020$4,000
-82.6%
676
-68.5%
0.00%
Q3 2020$23,0000.0%2,1470.0%0.00%
Q2 2020$23,0002,147
+6034.3%
0.00%
Q1 2020$0
-100.0%
35
-58.3%
0.00%
Q4 2019$1,0000.0%84
-54.3%
0.00%
Q3 2019$1,000184
+1126.7%
0.00%
Q3 2018$0150.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Opaleye Management Inc. 984,692$10,664,0002.09%
EAM Investors, LLC 71,866$778,0000.18%
B. Riley Wealth Advisors, Inc. 145,887$1,580,0000.08%
MARTINGALE ASSET MANAGEMENT L P 19,805$215,0000.00%
NISA INVESTMENT ADVISORS, LLC 19,069$207,0000.00%
Renaissance Technologies 75,941$822,0000.00%
Tower Research Capital LLC (TRC) 6,906$75,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1,367$14,805,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 3,984$43,0000.00%
BANK OF AMERICA CORP /DE/ 1,726$19,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders